Technical Analysis for VODG - Vitro Diagnostics
ADX | Long-Term | Intermediate-Term | Short-Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
See historical VODG trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Wide Bands | Range Expansion | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -11.11% | |
Calm After Storm | Range Contraction | -11.11% | |
Narrow Range Bar | Range Contraction | -11.11% | |
Inside Day | Range Contraction | -11.11% | |
Wide Bands | Range Expansion | -11.11% | |
50 DMA Resistance | Bearish | -8.57% | |
Fell Below 20 DMA | Bearish | -8.57% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Sector: Healthcare
- Industry: Biotechnology
Vitro Diagnostics, Inc., doing business as Vitro Biopharma, is engaged in the development, manufacturing and distribution of stem cell products and related tools for use in research, drug discovery and clinical trials. The Company's clinical products include clinical grade MSC-Gro for mesenchymal stem cell (MSC) expansion prior to transplantation; an equine MSC cell line with application to treatment of skeletal muscular conditions, such as tendonitis, ligament injury, osteoarthritis and accelerated bone fracture healing, and others; testing and therapies related to endogenous stem cell activation; diagnostic testing of stem cell activation and determination of stem cell functional status, and cell-based assays for discovery of stem cell activation agents and new drugs for the treatment of osteoporosis. The Company offers cancer-associated fibroblasts (CAFs), which are used in the discovery of a new type of CAFs present in pancreatic cancer tumors, called pancreatic stellate cells.
Manufacturing Biotechnology Branches Of Biology Life Sciences Biology Stem Cells Drug Discovery Tumor Osteoarthritis Osteoporosis Transplantation Stem Cell Therapy Induced Stem Cells Treatment Of Osteoporosis Clinical Products Mesenchymal Stem Cell Stem Cell Products Tendonitis
Manufacturing Biotechnology Branches Of Biology Life Sciences Biology Stem Cells Drug Discovery Tumor Osteoarthritis Osteoporosis Transplantation Stem Cell Therapy Induced Stem Cells Treatment Of Osteoporosis Clinical Products Mesenchymal Stem Cell Stem Cell Products Tendonitis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Date | Title |
---|
Indicator | Value |
---|---|
52 Week High | 0.4495 |
52 Week Low | 0.0321 |
Average Volume | 20,801 |
200-Day Moving Average | 0.2201 |
50-Day Moving Average | 0.2060 |
20-Day Moving Average | 0.2017 |
10-Day Moving Average | 0.1896 |
Average True Range | 0.0246 |
ADX | 19.15 |
+DI | 20.6122 |
-DI | 47.2886 |
Chandelier Exit (Long, 3 ATRs ) | 0.1762 |
Chandelier Exit (Short, 3 ATRs ) | 0.2188 |
Upper Bollinger Band | 0.2507 |
Lower Bollinger Band | 0.1527 |
Percent B (%b) | 0.07 |
BandWidth | 48.5870 |
MACD Line | -0.0097 |
MACD Signal Line | -0.0047 |
MACD Histogram | -0.005 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.1975 | ||||
Resistance 3 (R3) | 0.2017 | 0.1933 | 0.1913 | ||
Resistance 2 (R2) | 0.1933 | 0.1838 | 0.1913 | 0.1892 | |
Resistance 1 (R1) | 0.1767 | 0.1779 | 0.1725 | 0.1725 | 0.1871 |
Pivot Point | 0.1683 | 0.1683 | 0.1663 | 0.1663 | 0.1683 |
Support 1 (S1) | 0.1517 | 0.1588 | 0.1475 | 0.1475 | 0.1329 |
Support 2 (S2) | 0.1433 | 0.1529 | 0.1413 | 0.1308 | |
Support 3 (S3) | 0.1267 | 0.1433 | 0.1288 | ||
Support 4 (S4) | 0.1225 |